First Sign Drug of Abuse Urine Screening Test
Enzyme Immunoassay, Methadone. 510(k) K052197, from W.H.P.M., Inc. (Beverly, MA). Product code DJR, class 2.
As of Nov 21, 2026, K052197 is an FDA 510(k) held by W.H.P.M., Inc., substantially equivalent on Jun 9, 2006 after 301 days, with no recalls tied to it in FDA's recall database.
- Review time: 301 days
- Recalls: 0
The First Sign Drug of Abuse Tests are rapid, chromatographic immunoassays for the qualitative detection of drugs-of-abuse in human urine. The tests may be run singly or in combinations of up to six drugs simultaneously.
- Acon Bzo One Step Benzodiazepines Test Strip; Acon Bzo One Step Benzodiazepines Test DeviceK012300 · ACON Laboratories, Inc. · Sep 17, 2001
- Acon Oxy Ii One Step Oxycodone Test Strip; Test DeviceK043507 · ACON Laboratories, Inc. · Feb 25, 2005
- Acon Bar Ii One Step Barbiturates Test Strip & DeviceK050593 · ACON Laboratories, Inc. · May 6, 2005
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Aug 12, 2005
- Review panel
- Clinical Toxicology
- Regulation
- 21 CFR 862.3620
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files